 Antares Pharma Inc NASDAQ: ATRS shares are trading higher Wednesday after the company announced it will be acquired by Halozyme Therapeutics Inc NASDAQ: HALO for 5.60 per share in cash, valuing Antares at approximately 960 million. The transaction was unanimously approved. 